Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

This publication has 19 references indexed in Scilit:

• Pathogenesis of cystic fibrosis
  Published by Elsevier ,1993
• Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients
  The Journal of Infectious Diseases, 1992
• Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis
  The Lancet, 1991
• Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
  The Lancet, 1991
• Serotype-Specific Serum IgG Antibodies to Lipopolysaccharides of Pseudomonas aeruginosa in Cystic Fibrosis: Correlation to Disease, Subclass Distribution, and Experimental Protective Capacity
  Pediatric Research, 1990
• Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
  Journal of Clinical Investigation, 1989
• Antipseudomonal therapy in cystic fibrosis: Aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin
  European Journal of Clinical Microbiology & Infectious Diseases, 1989
• Management of Pseudomonas Aeruginosa Lung Infection in Danish Cystic Fibrosis Patients
  Acta Paediatrica, 1987
• Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
  Journal of Clinical Investigation, 1984
• The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis
  The Journal of Pediatrics, 1981